There are 412 resources available
26P - Lipidic and T cell characterization as prognostic biomarkers for patients with ER+ HER2- metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK4/6i)
Presenter: Letizia Negrini
Session: Lunch and Poster Display session
27P - Impact of chemotherapy (CT) use and stromal tumor-infiltrating lymphocytes (sTILs) in stage I triple-negative breast cancer (TNBC)
Presenter: Vittoria Barberi
Session: Lunch and Poster Display session
28P - The Ki67 proliferation index in subtypes of human DCIS grade III: A biomarker with potential impact on clinical decision making?
Presenter: Hossein Schandiz
Session: Lunch and Poster Display session
29P - Long-term performance of residual cancer burden (RCB): Clinical pathological stage (CPS) and CPS+ER+Grade (CPS-EG) models in ER+HER2- breast cancer (BC) patients (pts) after neoadjuvant chemotherapy (NAC) - Role of Ki67 drop and extended endocrine therapy (EET)
Presenter: Lucia Sanz Gomez
Session: Lunch and Poster Display session
30P - E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Presenter: Lounes Djerroudi
Session: Lunch and Poster Display session
31P - Crown-like structures are associated with changes in immune cell infiltrates and gene signatures in patients with primary invasive breast cancer
Presenter: Constantinos Savva
Session: Lunch and Poster Display session
32P - Genomic risk classification and whole transcriptome analysis of HR+/HER2- post-partum breast cancers: A FLEX sub study
Presenter: Virginia Borges
Session: Lunch and Poster Display session
33P - Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors
Presenter: Gaia Griguolo
Session: Lunch and Poster Display session
34P - Premenopausal breast cancer and CYP27A1 expression: A cholesterol-associated biomarker
Presenter: Jeppe Skovbjerg
Session: Lunch and Poster Display session
35P - Genomic and clinical landscape of metastatic hormone receptor-positive breast cancers carrying ESR1 alterations
Presenter: Luca Boscolo Bielo
Session: Lunch and Poster Display session